within Pharmacolibrary.Drugs.N_NervousSystem.N05A_Antipsychotics.N05AF02_Clopenthixol;

model Clopenthixol
  extends Pharmacolibrary.Drugs.ATC.N.N05AF02;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>N05AF02</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Clopenthixol is a typical thioxanthene antipsychotic drug primarily used for the management of schizophrenia and other psychotic disorders. Its use today is limited in several countries but remains approved and in clinical use in some regions, particularly in Europe, for both acute and chronic psychoses.</p><h4>Pharmacokinetics</h4><p>Estimated pharmacokinetic parameters for healthy adult individuals, as there are no direct reference publications with detailed PK models for clopenthixol available.</p><h4>References</h4><ol><li><p>Spanarello, S, &amp; La Ferla, T (2014). The pharmacokinetics of long-acting antipsychotic medications. <i>Current clinical pharmacology</i> 9(3) 310–317. DOI:<a href=\"https://doi.org/10.2174/15748847113089990051\">10.2174/15748847113089990051</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/23343447/\">https://pubmed.ncbi.nlm.nih.gov/23343447</a></p></li><li><p>Jann, MW, et al., &amp; Saklad, SR (1985). Clinical pharmacokinetics of the depot antipsychotics. <i>Clinical pharmacokinetics</i> 10(4) 315–333. DOI:<a href=\"https://doi.org/10.2165/00003088-198510040-00003\">10.2165/00003088-198510040-00003</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/2864156/\">https://pubmed.ncbi.nlm.nih.gov/2864156</a></p></li><li><p>Altamura, AC, et al., &amp; Mundo, E (2003). Intramuscular preparations of antipsychotics: uses and relevance in clinical practice. <i>Drugs</i> 63(5) 493–512. DOI:<a href=\"https://doi.org/10.2165/00003495-200363050-00004\">10.2165/00003495-200363050-00004</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/12600227/\">https://pubmed.ncbi.nlm.nih.gov/12600227</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end Clopenthixol;
